Resistance modification by PSC-833, a novel non-immunosuppressive cyclosporin A
- 31 December 1991
- journal article
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 27 (12) , 1639-1642
- https://doi.org/10.1016/0277-5379(91)90435-g
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- A pilot study of quinidine and epirubicin in the treatment of advanced breast cancerBritish Journal of Cancer, 1990
- Chemosensitisation by verapamil and cyclosporin A in mouse tumour cells expressing different levels of P-glycoprotein and CP22 (sorcin)British Journal of Cancer, 1990
- Overcoming multidrug resistance in Chinese hamster ovary cells in vitro by cyclosporin A (Sandimmune) and non-immunosuppressive derivativesBritish Journal of Cancer, 1989
- Amplification and expression of mdr1 gene in a multidrug resistant variant of small cell lung cancer cell line NCI-H69British Journal of Cancer, 1989
- Drug-resistance in multiple myeloma and non-Hodgkin's lymphoma: detection of P-glycoprotein and potential circumvention by addition of verapamil to chemotherapy.Journal of Clinical Oncology, 1989
- Modification of cytotoxic drug resistance by non-immuno-suppressive cyclosporinsBritish Journal of Cancer, 1988
- Cyclosporin A and its analogues as modifiers of adriamycin and vincristine resistance in a multi-drug resistant human lung cancer cell lineBritish Journal of Cancer, 1987
- Derivation and preliminary characterisation of adriamycin resistant lines of human lung cancer cellsBritish Journal of Cancer, 1986
- Cyclosporin A reverses vincristine and daunorubicin resistance in acute lymphatic leukemia in vitro.Journal of Clinical Investigation, 1986
- Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assaysJournal of Immunological Methods, 1983